Related Practice Life Sciences & Pharma The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies 01262022170133
Podcast Life Sciences & Pharma Scope 3 Emissions: A Strategic Imperative for Pharma Companies May 8, 2024
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Executive Insights Mergers & Acquisitions Keys to Unlocking Merger Value — Revenue Synergies December 18, 2023
Article Life Sciences & Pharma The SEA Healthcare, Medtech, and Pharma Landscape in 2023 December 7, 2023